Clinical trial

Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy

NCT00432055 · Sunnaas Rehabilitation Hospital, Other · Completed

Key facts

NCT number NCT00432055
Title Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy
Official title A Randomized Controlled Trial on Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy
Lead sponsor Sunnaas Rehabilitation Hospital, Other
Collaborators The Royal Norwegian Ministry of Health
Status Completed
Phase Phase 4
Study type Interventional
Conditions Cerebral Palsy
Intervention type Drug
Interventions Botulinum toxin type A (Botox), placebo (saline)
Enrollment 66
Start date Jan 1, 2007
Primary completion Jan 1, 2009
Completion Jan 1, 2009
First posted Feb 6, 2007
Last update posted Feb 24, 2009
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies